← Open Payments lookup

CAROLYN LE: Open Payments

NPI 1477212728 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,945 in 153 payments from 15 companies in 2025. Trend: 2023 $3,156 · 2024 $2,514 · 2025 $2,945

Food & beverage: $2,945
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)38$657
ABBVIE INC.29$443
Alkermes, Inc.14$299
Teva Pharmaceuticals USA, Inc.16$280
Vanda Pharmaceuticals Inc.12$269
Lundbeck LLC11$232
Axsome Therapeutics, Inc.7$153
E.R. Squibb & Sons, L.L.C.5$150
Indivior Inc.4$107
Neurocrine BioSciences, Inc.4$107

Products named: CAPLYTA, VRAYLAR, ARISTADA, FANAPT, REXULTI, UZEDY, Auvelity, COBENFY.

Industry payments across CA — which companies pay providers there.